Today's Daily Dose brings you news about Kala Pharma's completion of enrollment in STRIDE 3 trial, Rockwell Medical's license and supply agreements with India-based Sun Pharmaceutical and upcoming regulatory catalyst of DURECT.
from RTT - Biotech https://ift.tt/2RrpEi6
via IFTTT
No comments:
Post a Comment